179 related articles for article (PubMed ID: 9833394)
1. Expression of adhesion molecule CD44 in metastatic brain tumors.
Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
[TBL] [Abstract][Full Text] [Related]
2. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
Woodman AC; Sugiyama M; Yoshida K; Sugino T; Borgya A; Goodison S; Matsumura Y; Tarin D
Am J Pathol; 1996 Nov; 149(5):1519-30. PubMed ID: 8909242
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids.
Rainaldi G; Calcabrini A; Arancia G; Santini MT
Anticancer Res; 1999; 19(3A):1769-78. PubMed ID: 10470114
[TBL] [Abstract][Full Text] [Related]
4. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
[TBL] [Abstract][Full Text] [Related]
5. [CD44 expression patterns in primary and secondary brain tumors].
Li H; Liu J; Hofmann M
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):525-8, 573. PubMed ID: 8556541
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
Wei KC; Huang CY; Chen PY; Feng LY; Wu TW; Chen SM; Tsai HC; Lu YJ; Tsang NM; Tseng CK; Pai PC; Shin JW
Anticancer Res; 2010 Jan; 30(1):253-9. PubMed ID: 20150644
[TBL] [Abstract][Full Text] [Related]
7. αv-Integrin isoform expression in primary human tumors and brain metastases.
Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
[TBL] [Abstract][Full Text] [Related]
9. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
de la Torre M; Heldin P; Bergh J
Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
[TBL] [Abstract][Full Text] [Related]
10. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
11. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
[TBL] [Abstract][Full Text] [Related]
12. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
14. Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms.
Mittelbronn M; Warth A; Meyermann R; Goodman S; Weller M
Histol Histopathol; 2013 Jun; 28(6):749-58. PubMed ID: 23238957
[TBL] [Abstract][Full Text] [Related]
15. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
Dehmel A; Becker M; Lemm M; Fichtner I
Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.
Jaskiewicz K; Chasen MR
Anticancer Res; 1995; 15(2):559-62. PubMed ID: 7539239
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
19. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.
Petrovich Z; Yu C; Giannotta SL; O'Day S; Apuzzo ML
J Neurosurg; 2002 Dec; 97(5 Suppl):499-506. PubMed ID: 12507085
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
